Medical devices, healthcare technology and the business of care
510(k) clearance · K261217

AnyPlus II Spinal Fixation System

GS Medical Co., Ltd. · Decision date Oct 2, 2026

MEDTECHLEDGER EXPLANATIONK261217

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-02 for the AnyPlus II Spinal Fixation System, submitted by GS Medical Co., Ltd. of Cheongju-Si, Republic of Korea, under 510(k) number K261217. The device falls under the classification name Thoracolumbosacral Pedicle Screw System, regulation number 888.3070, with primary product code NKB and subsequent product codes KWP and KWQ. The regulation medical specialty and 510(k) review panel are both listed as Orthopedic.

The application was received on 04/14/2026 and reviewed by FDA rather than a third party; the record lists it as a special type, not a combination product, and no Predetermined Change Control Plan was authorized. A SESE decision indicates clearance to market through the 510(k) pathway, not premarket approval. The public record does not describe the specific components, materials, sizes or any changed item relative to a predicate device, and no summary statement is included, so the technical basis for equivalence remains unknown from these sources.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261217
Regulatory pathway
510(k) premarket notification
Product code
NKB
Decision code
SESE
Decision date
Oct 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Thoracolumbosacral Pedicle Screw System.

Product code
NKB
FDA device class
2

FDA decision timeline

  1. K261217 received

    Application receipt date recorded by FDA.

  2. K261217 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NKB

Product / regulatory recordCompanyPathwayDecision dateSource
SeaSpine Orthopedics Corporation510(k) clearanceOct 29, 2026FDA
Tdm Co., Ltd.510(k) clearanceOct 1, 2026FDA
Duet Spine Holdings, LLC510(k) clearanceSep 30, 2026FDA
Spinal Alignment Solutions, Inc.510(k) clearanceSep 30, 2026FDA
Rivarp Medical Pvt., Ltd.510(k) clearanceSep 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

GS Medical Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Cheongju-Si

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records